MARKET

INCPF

INCPF

Innocare Pharma
OTCPK
2.050
NaN%
Closed 09:30 07/24 EDT
OPEN
--
PREV CLOSE
2.050
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
2.310
52 WEEK LOW
2.050
MARKET CAP
3.06B
P/E (TTM)
38.46
1D
5D
1M
3M
1Y
5Y
1D
UBS Reaffirms Their Buy Rating on InnoCare Pharma Ltd. (9969)
TipRanks · 07/17 09:55
InnoCare’s TYK2 Inhibitor Soficitinib Delivers Positive Phase II Results in Non-Segmental Vitiligo
TipRanks · 07/16 09:16
InnoCare’s TYK2 Inhibitor Soficitinib Hits Phase III Goal in Atopic Dermatitis
TipRanks · 07/15 11:07
InnoCare Pharma Grants Performance-Linked RSUs Under 2023 Share Award Scheme
TipRanks · 06/30 11:40
InnoCare Shareholders Approve All Resolutions at 2026 AGM
TipRanks · 06/16 13:03
InnoCare Pharma Launches 2026 RMB Share Incentive Scheme with First Grant of Restricted Shares
TipRanks · 06/16 13:01
InnoCare Pharma Names New Joint Company Secretary and Secures Listing Rules Waiver
TipRanks · 06/05 10:57
InnoCare Pharma upgraded to Overweight from Equal Weight at Morgan Stanley
TipRanks · 05/28 21:07
More
About INCPF
InnoCare Pharma Ltd is a China-based company mainly engaged in the research and development, production and commercialization of biopharmaceuticals. The Company focuses on areas with unmet clinical needs, such as oncology and autoimmune diseases. The Company's primary product pipeline includes Orelabrutinib, Tafasitamab, ICP-490, ICP-B02, ICP-248, ICP-B05, ICP-332, ICP-488, ICP-192, ICP-723, ICP-033 and ICP-189, and others. Its products are mainly used to treat hematological tumors, solid tumors and autoimmune diseases. The Company is also developing products for the treatment of autoimmune diseases caused by abnormal T cell function. The Company conducts its businesses in domestic and overseas markets.

Webull offers InnoCare Pharma Ltd stock information, including OTCPK: INCPF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INCPF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading INCPF stock methods without spending real money on the virtual paper trading platform.